These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34726261)

  • 1. Identification of patients at high risk of secondary extramedullary multiple myeloma development.
    Stork M; Sevcikova S; Minarik J; Krhovska P; Radocha J; Pospisilova L; Brozova L; Jarkovsky J; Spicka I; Straub J; Pavlicek P; Jungova A; Jelinek T; Sandecka V; Maisnar V; Hajek R; Pour L
    Br J Haematol; 2022 Feb; 196(4):954-962. PubMed ID: 34726261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of extramedullary disease on patients with newly diagnosed multiple myeloma].
    Tao Y; Jin SW; Wang Y; Tang SJ; Liu YF; Xu J; Pan MM; Zhang WP; Mi JQ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):48-54. PubMed ID: 36987723
    [No Abstract]   [Full Text] [Related]  

  • 3. Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
    Stork M; Sevcikova S; Jelinek T; Minarik J; Radocha J; Pika T; Pospisilova L; Spicka I; Straub J; Pavlicek P; Jungova A; Knechtova Z; Sandecka V; Maisnar V; Hajek R; Pour L
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study.
    Gao S; Li Q; Dong F; Yang P; Chen Y; Wang J; Wang Y; Jing H
    Leuk Res; 2022 Apr; 115():106793. PubMed ID: 35248783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10].
    Zhao JT; Jiang XY; Yang C; Chen M; Lan XL; Du JH; Zhou DB; Zhuang JL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):295-301. PubMed ID: 33979973
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical Analysis of 46 Cases of Multiple Myeloma with Extramedullary Disease].
    Chao Y; Fan L; Gao XY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):115-121. PubMed ID: 33554807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor.
    Wang Y; Liu A; Xu T; Yin J; Chen W
    Clin Med Insights Oncol; 2022; 16():11795549221109500. PubMed ID: 35875418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and outcomes of patients newly diagnosed with multiple myeloma with extramedullary disease].
    Wang J; Zhang LN; Shi QL; Qu XY; Chen LJ; Li JY; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):822-828. PubMed ID: 33190439
    [No Abstract]   [Full Text] [Related]  

  • 10. High nuclear expression of Twist1 in the skeletal extramedullary disease of myeloma patients predicts inferior survival.
    Yang JZ; Lian WG; Sun LX; Qi DW; Ding Y; Zhang XH
    Pathol Res Pract; 2016 Mar; 212(3):210-6. PubMed ID: 26774288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pomalidomide-based therapy for extramedullary multiple myeloma.
    Li Y; Ji J; Lu H; Li J; Qu X
    Hematology; 2022 Dec; 27(1):88-94. PubMed ID: 35068387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Propensity Score Matching Study of Autologous Hematopoietic Stem Cell Transplantation and New Drug Chemotherapy for Newly Diagnosed Multiple Myeloma].
    Yang FY; Wang HF; Xia LH; Wang QQ; Qian CJ; He J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):158-165. PubMed ID: 35123620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of the Expression of CD56 in Multiple Myeloma with Bone-Related Extramedullary Diseases.
    Chen Q; Zheng X; Lin Q; Chen J
    Ann Clin Lab Sci; 2023 Jan; 53(1):14-20. PubMed ID: 36889774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease.
    Tucker SM; Zaihra T
    Orbit; 2023 Dec; 42(6):603-611. PubMed ID: 36697375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of increased microvessel density with skeletal extramedullary disease relapse in multiple myeloma patients who have skeletal extramedullary disease at diagnosis.
    Yang JZ; Wu XD; Meng JB; Zhang JQ; Sun LX
    Pathol Res Pract; 2018 Oct; 214(10):1694-1699. PubMed ID: 30196985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Prognostic Analysis of Multiple Myeloma with Extramedullary Disease: A SEER-Based Study.
    Li G; Song YP; Lv Y; Li ZZ; Zheng YH
    J Oncol; 2021; 2021():6681521. PubMed ID: 33603785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the Prognostic Value and Risk Factors of Early Relapse for Newly Diagnosed Multiple Myeloma Patients in the Era of Novel Agents].
    Li QH; Liu Y; Wang J; Wang JJ; Dong F; Yang P; Wan W; Ke XY; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):148-153. PubMed ID: 36765492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.
    Cohen YC; Saranga A; Gatt ME; Lavi N; Ganzel C; Magen H; Avivi I; Tadmor T; Suriu C; Jarchowsky Dolberg O; Papushado A; Trestman S; Ram R
    Am J Hematol; 2018 Jun; 93(6):810-815. PubMed ID: 29603773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].
    Wang CY; Wu L; Sun CT; Wang X; Xia B; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):301-306. PubMed ID: 30669718
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients.
    Yue X; He D; Zheng G; Yang Y; Han X; Li Y; Zhao Y; Wu W; Chen Q; Zhang E; Cai Z; He J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.